Literature DB >> 12084332

Phytotherapy for chronic prostatitis.

F C Lowe1, E Fagelman.   

Abstract

Chronic prostatitis is a poorly defined condition that is difficult to treat; there are therefore multiple therapies. Although there is a paucity of trials using phytotherapeutic agents, plant extracts have been postulated to have anti-inflammatory effects that might be useful in the treatment of chronic prostatitis. More placebo-controlled trials of longer duration in this condition are needed to ascertain whether there is a significant benefit to the use of phytotherapeutic agents for chronic prostatitis.

Entities:  

Mesh:

Year:  2000        PMID: 12084332     DOI: 10.1007/s11934-000-0053-x

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  18 in total

Review 1.  Phytotherapy in the treatment of benign prostatic hyperplasia: an update.

Authors:  F C Lowe; E Fagelman
Journal:  Urology       Date:  1999-04       Impact factor: 2.649

Review 2.  Phytotherapy for the prostate.

Authors:  A C Buck
Journal:  Br J Urol       Date:  1996-09

3.  Comparison of finasteride (Proscar) and Serenoa repens (Permixon) in the inhibition of 5-alpha reductase in healthy male volunteers.

Authors:  G Strauch; P Perles; G Vergult; M Gabriel; B Gibelin; S Cummings; W Malbecq; M P Malice
Journal:  Eur Urol       Date:  1994       Impact factor: 20.096

4.  Effect of the lipidic lipidosterolic extract of Serenoa repens (Permixon) on the ionophore A23187-stimulated production of leukotriene B4 (LTB4) from human polymorphonuclear neutrophils.

Authors:  M Paubert-Braquet; J M Mencia Huerta; H Cousse; P Braquet
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1997-09       Impact factor: 4.006

5.  Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial.

Authors:  D A Shoskes; S I Zeitlin; A Shahed; J Rajfer
Journal:  Urology       Date:  1999-12       Impact factor: 2.649

6.  Effects of tadenan pretreatment on bladder physiology and biochemistry following partial outlet obstruction.

Authors:  R M Levin; J P Riffaud; F Bellamy; D Rohrmann; L Krasnopolsky; N Haugaard; Y Zhao; A J Wein
Journal:  J Urol       Date:  1996-12       Impact factor: 7.450

7.  Inhibition of androgen metabolism and binding by a liposterolic extract of "Serenoa repens B" in human foreskin fibroblasts.

Authors:  C Sultan; A Terraza; C Devillier; E Carilla; M Briley; C Loire; B Descomps
Journal:  J Steroid Biochem       Date:  1984-01       Impact factor: 4.292

8.  [Inhibition of arachidonic acid cascade by extract of rye pollen].

Authors:  G Loschen; L Ebeling
Journal:  Arzneimittelforschung       Date:  1991-02

9.  Comparison of finasteride (Proscar), a 5 alpha reductase inhibitor, and various commercial plant extracts in in vitro and in vivo 5 alpha reductase inhibition.

Authors:  L Rhodes; R L Primka; C Berman; G Vergult; M Gabriel; M Pierre-Malice; B Gibelin
Journal:  Prostate       Date:  1993       Impact factor: 4.104

10.  How important are prostaglandins in the urology of man?

Authors:  D Bach; H Walker
Journal:  Urol Int       Date:  1982       Impact factor: 2.089

View more
  2 in total

Review 1.  The management of chronic prostatitis in men with HIV.

Authors:  Vincent M Santillo; Franklin C Lowe
Journal:  Curr Urol Rep       Date:  2006-07       Impact factor: 3.092

2.  Complementary and alternative medicine for chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Jillian L Capodice; Debra L Bemis; Ralph Buttyan; Steven A Kaplan; Aaron E Katz
Journal:  Evid Based Complement Alternat Med       Date:  2005-10-10       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.